KIT and neoplasm: In human neoplasms, c-kit mutations have been indicated to provoke constitutive (independent from its ligand) KIT phosphorylation and activation by impairing the regulatory functions of the juxtamembrane domain and by directly targeting the kinase domain [25,26,27].